发明名称 |
HYDROXAMIC ACID DERIVATIVE AND PHARMACEUTICAL USE THEREOF |
摘要 |
Hydroxamic acid derivatives represented by general formula (I) or pharmacologically acceptable salts thereof; medicinal compositions containin g the same and medicinal utilization thereof wherein each symbol has the meani ng as defined in the specification. Because of having TNF-.alpha. production inhibitory effect, these derivatives or pharmacologically acceptable salts thereof are useful in preventing/treating autoimmune diseases and inflammato ry diseases, for example, sepsis, MOF, rheumatoid arthritis, Crohn's disease, cachexia, myasthenia gravis, systemic lupus erythematosus, asthma, I type diabetes and psoriasis.
|
申请公布号 |
CA2332946(A1) |
申请公布日期 |
1999.12.02 |
申请号 |
CA19992332946 |
申请日期 |
1999.05.19 |
申请人 |
WELFIDE CORPORATION |
发明人 |
TAKEDA, SHINJI;MAEDA, KAZUHIRO;YOSHIDA, TOMOHIRO;SUGIYAMA, NAOKI;TAKEMOTO, TADAHIRO;GOTOU, TOMOKAZU |
分类号 |
A61P19/02;C07C259/06;C07D209/46;C07D209/48;C07D233/72;C07D307/52;C07D309/12;C07D405/12;C07D405/14;(IPC1-7):C07C259/06;C07D401/12;C07D403/12;C07D407/12;C07D409/12;C07D417/12;C07D409/14;C07C233/31;C07D207/32;C07D233/34;A61K31/34;A61K31/38;C07D333/40;A61K31/40;A61K31/415;A61K31/425;A61K31/44;C07D307/46;A61K31/495 |
主分类号 |
A61P19/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|